comparemela.com

Latest Breaking News On - Zentalis pharmaceuticals company profile - Page 5 : comparemela.com

Fmr LLC Raises Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)

Fmr LLC Raises Stock Holdings in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Texas
United-states
Hong-kong
Stifel-nicolaus
Zurcher-kantonalbank-zurich-cantonalbank
Zentalis-pharmaceuticals-company-profile
Zentalis-pharmaceuticals-price-performance
Hong-kong-ltd
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-inc
Securities-exchange-commission
Us-bancorp

Analysts Set Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) PT at $47.10

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) have earned an average recommendation of “Buy” from the seven analysts that are currently covering the stock, MarketBeat reports. Seven investment analysts have rated the stock with a buy recommendation. The average 1-year price target among brokers that have issued ratings on the stock in […]

Stifel-nicolaus
Analyst-recommendations-for-zentalis-pharmaceuticals
Zentalis-pharmaceuticals
Zentalis-pharmaceuticals-company-profile
Zentalis-pharmaceuticals-stock
Blackrock-inc
Securities-exchange-commission
News-ratings-for-zentalis-pharmaceuticals-daily
Zentalis-pharmaceuticals-inc
Nasdaq
Wells-fargo-company

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Receives Consensus Recommendation of "Buy" from Analysts

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Free Report) has received an average recommendation of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 1-year target price among analysts that have issued ratings on the stock in the last […]

Hong-kong
Zurcher-kantonalbank-zurich-cantonalbank
Stifel-nicolaus
Insider-transactions-at-zentalis-pharmaceuticals
Zentalis-pharmaceuticals-stock-performance
Institutional-trading-of-zentalis-pharmaceuticals
Nasdaq
Zentalis-pharmaceuticals-inc
Zentalis-pharmaceuticals-company-profile
Hong-kong-ltd
Us-bancorp
Analyst-recommendations-for-zentalis-pharmaceuticals

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL) Given Consensus Recommendation of "Buy" by Brokerages

Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) has been given a consensus recommendation of “Buy” by the twelve research firms that are covering the stock, MarketBeat.com reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have issued a report on the stock in the […]

Hong-kong
Stifel-nicolaus
Hong-kong-ltd
Us-bancorp
Zentalis-pharmaceuticals-inc
Life-insurance-co
Analyst-recommendations-for-zentalis-pharmaceuticals
Nasdaq
Jefferies-financial-group
Zentalis-pharmaceuticals-company-profile
Zentalis-pharmaceuticals-stock-down
Great-west-life-assurance-co

Opaleye Management Inc. Buys New Shares in Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL)

Opaleye Management Inc. bought a new stake in shares of Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL – Get Rating) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 167,500 shares of the company’s stock, valued at approximately $3,373,000. Zentalis Pharmaceuticals comprises about 1.2% of […]

Arizona
United-states
Stifel-nicolaus
Zentalis-pharmaceuticals
Opaleye-management-inc
Zentalis-pharmaceuticals-inc
Jefferies-financial-group
Life-insurance-co
Zentalis-pharmaceuticals-company-profile
Zentalis-pharmaceuticals-price-performance
Proshare-advisors
Nasdaq

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.